How pharma companies can leverage their IP rights
01 October 2008
Pharmaceutical companies are adopting new IP strategies to stay competitive. Rakesh Mishra and GVS Sesha Kumar review some of the most successful examples
The way in which the pharmaceutical company uses IP depends largely on its business strategy; its size, resources, innovative capacity, competitive arena and field of expertise. Without any doubt the patent system has played and will continue to play a vital role in the growth of the pharmaceutical industry. A patent is a powerful business tool that allows a company to gain exclusivity in the market over a new product or process, develop a strong market position and earn additional profits through licensing. In some countries, a longer period of protection may be obtained for pharmaceutical products to compensate for the loss of the effective period of protection due to delays in obtaining marketing approval from the relevant public health regulatory bodies....
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial